Skip to main content
Log in

A mismatch repair-deficient and HPV-negative anorectal squamous cell carcinoma

  • Brief Report
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Invasive primary squamous cell carcinomas involving the anorectal region are challenging to manage. Microsatellite instability has been shown to impact clinical courses and outcomes of patients affected by many types of carcinomas. To the best of our knowledge, there are no reports on microsatellite instability in anorectal squamous cell carcinomas. Here, we report a HPV-negative anorectal squamous cell carcinoma which, despite cisplatin-based chemoradiation therapy, showed progression. Interestingly, after identification of its mismatch repair-deficiency (MLH1/PMS2-absent, MSH2/MSH6-intact), pembrolizumab-based immunotherapy was initiated, leading to a marked clinical response. This unique case illustrates that microsatellite instability testing and immunotherapy targeting immune checkpoint blockade should be considered for managing anorectal squamous cell carcinomas that fail conventional chemoradiation therapies or when patients are non-surgical candidates. This report provides the first evidence of microsatellite instability in anorectal squamous cell carcinomas and supports the role for microsatellite instability testing in this cancer type to optimize patient management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Shia J (2010) An update on tumors of the anal canal. Arch Pathol Lab Med 134(11):1601–1611. https://doi.org/10.1043/2009-0668-RAR.1

    Article  PubMed  Google Scholar 

  2. Mai S, Welzel G, Ottstadt M, Lohr F, Severa S, Prigge ES, Wentzensen N, Trunk MJ, Wenz F, von Knebel-Doeberitz M, Reuschenbach M (2015) Prognostic relevance of HPV infection and p16 overexpression in squamous cell anal cancer. Int J Radiat Oncol Biol Phys 93(4):819–827. https://doi.org/10.1016/j.ijrobp.2015.08.004

    Article  CAS  PubMed  Google Scholar 

  3. Martin D, Rodel F, Balermpas P, Rodel C, Fokas E (2017) The immune microenvironment and HPV in anal cancer: rationale to complement chemoradiation with immunotherapy. Biochim Biophys Acta 1868(1):221–230. https://doi.org/10.1016/j.bbcan.2017.05.001

    Article  CAS  Google Scholar 

  4. Martin D, Balermpas P, Winkelmann R, Rodel F, Rodel C, Fokas E (2018) Anal squamous cell carcinoma - state of the art management and future perspectives. Cancer Treat Rev 65:11–21. https://doi.org/10.1016/j.ctrv.2018.02.001

    Article  PubMed  Google Scholar 

  5. Bonneville R, Krook MA, Kautto EA, Miya J, Wing MR, Chen H-Z, Reeser JW, Yu L, Roychowdhury S (2017) Landscape of microsatellite instability across 39 cancer types. JCO Precision Oncology (1):1–15. https://doi.org/10.1200/po.17.00073

  6. Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, Xiao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr (2017) Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 357(6349):409–413. https://doi.org/10.1126/science.aan6733

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ruemmele P, Dietmaier W, Terracciano L, Tornillo L, Bataille F, Kaiser A, Wuensch PH, Heinmoeller E, Homayounfar K, Luettges J, Kloeppel G, Sessa F, Edmonston TB, Schneider-Stock R, Klinkhammer-Schalke M, Pauer A, Schick S, Hofstaedter F, Baumhoer D, Hartmann A (2009) Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions. Am J Surg Pathol 33(5):691–704. https://doi.org/10.1097/PAS.0b013e3181983ef7

    Article  PubMed  Google Scholar 

  8. Sinicrope FA (2010) DNA mismatch repair and adjuvant chemotherapy in sporadic colon cancer. Nat Rev Clin Oncol 7(3):174–177. https://doi.org/10.1038/nrclinonc.2009.235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Ryan E, Sheahan K, Creavin B, Mohan HM, Winter DC (2017) The current value of determining the mismatch repair status of colorectal cancer: a rationale for routine testing. Crit Rev Oncol Hematol 116:38–57. https://doi.org/10.1016/j.critrevonc.2017.05.006

    Article  CAS  PubMed  Google Scholar 

  10. He EY, Hawkins NJ, Mak G, Roncolato F, Goldstein D, Liauw W, Clingan P, Chin M, Ward RL (2016) The impact of mismatch repair status in colorectal cancer on the decision to treat with adjuvant chemotherapy: an Australian population-based multicenter study. Oncologist 21(5):618–625. https://doi.org/10.1634/theoncologist.2015-0530

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Seya T, Tanaka N, Shinji S, Yokoi K, Oguro T, Oaki Y, Ishiwata T, Naito Z, Tajiri T (2007) Squamous cell carcinoma arising from recurrent anal fistula. J Nippon Med Sch 74(4):319–324

    Article  PubMed  Google Scholar 

  12. Field JK, Kiaris H, Howard P, Vaughan ED, Spandidos DA, Jones AS (1995) Microsatellite instability in squamous cell carcinoma of the head and neck. Br J Cancer 71(5):1065–1069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Tardy MP, Di Mauro I, Ebran N, Refae S, Bozec A, Benezery K, Peyrade F, Guigay J, Sudaka-Bahadoran A, Badoual C, Pedeutour F, Saada-Bouzid E (2018) Microsatellite instability associated with durable complete response to PD-L1 inhibitor in head and neck squamous cell carcinoma. Oral Oncol 80:104–107. https://doi.org/10.1016/j.oraloncology.2018.04.001

    Article  CAS  PubMed  Google Scholar 

  14. Feng YC, Ji WL, Yue N, Huang YC, Ma XM (2018) The relationship between the PD-1/PD-L1 pathway and DNA mismatch repair in cervical cancer and its clinical significance. Cancer Manag Res 10:105–113. https://doi.org/10.2147/CMAR.S152232

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We sincerely thank Dr. Bruce Wenig at Moffitt Cancer Center Pathology department for his expertise opinion and suggestions during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

Dr. Jiang conceived and designed the study, and wrote, edited, and reviewed the manuscript. Drs. Martens, Meyer, Truong, and Lauwers researched the data and edited and reviewed the manuscript. All authors gave the final approval for publication. Dr. Jiang takes full responsibility for the work, including the study design, access to data, and the decision to submit and publish the manuscript.

Corresponding author

Correspondence to Kun Jiang.

Ethics declarations

This is a brief report on a novel and unique case of diagnostic interest; it is not a research project; there is no Human or Animal participant(s). Informed consent was acquired although no confidential personal information was cited or disclosed in this brief report.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, K., Martens, B., Meyer, L. et al. A mismatch repair-deficient and HPV-negative anorectal squamous cell carcinoma. Virchows Arch 474, 769–773 (2019). https://doi.org/10.1007/s00428-019-02530-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-019-02530-y

Keywords

Navigation